Article
Androgen deprivation restores ARHGEF2 to promote neuroendocrine differentiation of prostate cancer
2022-06-22
Abstract excerpt
<title>Abstract</title> <p>Androgen receptor (AR) plays an important role in the progression of prostate cancer and has been targeted by castration or AR-antagonists. The emergence of castration-resistant prostate cancer (CRPC) after androgen deprivation therapy (ADT) is inevitable. However, it is not entirely clear how ADT fails or how it causes resistance. Through analysis of RNA-seq data, we nominate ARHGEF2 a...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8fe5eb2f-dcda-5a40-9710-ba9ba5fc531f
- DOI
- 10.21203/rs.3.rs-1738099/v1
